dc.contributor.author | Holliday, Deborah L | |
dc.contributor.author | Speirs, Valerie | |
dc.date.accessioned | 2019-04-22T12:50:07Z | |
dc.date.available | 2019-04-22T12:50:07Z | |
dc.date.issued | 2011-08-12 | |
dc.identifier | 129548866 | |
dc.identifier | 46b9abcf-9d5a-410c-8e93-6ec8d3c8b6f8 | |
dc.identifier | 21884641 | |
dc.identifier | 84860992007 | |
dc.identifier.citation | Holliday , D L & Speirs , V 2011 , ' Choosing the right cell line for breast cancer research ' , Breast Cancer Research , vol. 13 , 215 . https://doi.org/10.1186/bcr2889 | en |
dc.identifier.issn | 1465-5411 | |
dc.identifier.other | PubMedCentral: PMC3236329 | |
dc.identifier.other | ORCID: /0000-0002-0602-4666/work/94084749 | |
dc.identifier.uri | http://hdl.handle.net/2164/12196 | |
dc.description | The authors are supported by the Breast Cancer Campaign, the Dr Hadwen Trust for Humane Research and the Lord Dowding Fund for Humane Research. | en |
dc.format.extent | 360469 | |
dc.language.iso | eng | |
dc.relation.ispartof | Breast Cancer Research | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Animals | en |
dc.subject | Breast Neoplasms | en |
dc.subject | Cell Line, Tumor | en |
dc.subject | Estrogen Receptor alpha | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Mice | en |
dc.subject | Neoplastic Stem Cells | en |
dc.subject | Receptor, ErbB-2 | en |
dc.subject | Receptors, Progesterone | en |
dc.subject | Research Design | en |
dc.subject | Xenograft Model Antitumor Assays | en |
dc.subject | Journal Article | en |
dc.subject | Research Support, Non-U.S. Gov't | en |
dc.subject | Review | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Choosing the right cell line for breast cancer research | en |
dc.type | Journal item | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/bcr2889 | |
dc.identifier.vol | 13 | en |